Abstract
Humans have coevolved with the trillions of microorganisms that inhabit their body, namely human microbiome. The human microbiome, especially gut microbiome, has gained an extensive interest over the last decades due to state-of-the-art technology and large-scale metagenomics studies that attempt to unravel the mystery of this complex, heterogenous ecosystem and its repercussions to host physiology. Bacteria have been the center of attention across research literature, but here an overview of the role of fungi, archaea, viruses, and protozoa is addressed as well. The aim of this chapter is to explore the diversity of taxonomic composition of human microbiota and their pivotal role in regulating host metabolism, immune system, and protection against invading pathogens. The chapter also focuses on the potential external factors (initial colonization, diet, lifestyle) prompting variable configurations of human microbiota that lead to imbalance of homeostasis (dysbiosis) and result in a broad spectrum of pathological diseases, such as obesity, inflammatory bowel disease, and Clostridium difficile-induced diarrhea.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012;129(2):434–440.e4402. https://doi.org/10.1016/j.jaci.2011.10.025.
Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22. https://doi.org/10.1186/1471-230X-11-22.
Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol. 2014;12:164. https://doi.org/10.1186/1477-7819-12-164.
Andrès E, Loukili NH, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–9. https://doi.org/10.1503/cmaj.1031155.
Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun. 2009;77(6):2367–75. https://doi.org/10.1128/IAI.01520-08.
Atarashi K, Nishimura J, Shima T, et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455(7214):808–12. https://doi.org/10.1038/nature07240.
Back-Brito GN, da Mota AJ, de Souza Bernardes LÂ, et al. Effects of eating disorders on oral fungal diversity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(4):512–7. https://doi.org/10.1016/j.oooo.2011.10.007.
Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(6):852. https://doi.org/10.1016/j.chom.2015.05.012.
Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–40. https://doi.org/10.1016/S0140-6736(07)60750-8.
Bellono NW, Bayrer JR, Leitch DB, et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell. 2017;170(1):185–198.e16. https://doi.org/10.1016/j.cell.2017.05.034.
Belzer C, de Vos WM. Microbes inside—from diversity to function: the case of Akkermansia. ISME J. 2012;6(8):1449–58. https://doi.org/10.1038/ismej.2012.6.
Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646–52.e525. https://doi.org/10.1016/j.jaci.2011.04.060.
Borrel G, McCann A, Deane J, et al. Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome. ISME J. 2017;11(9):2059–74. https://doi.org/10.1038/ismej.2017.72.
Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res. 2006;60(1):24–9. https://doi.org/10.1203/01.pdr.0000220322.31940.29.
Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–55. https://doi.org/10.1038/nrmicro.2017.157.
Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes. 2015;39(9):1331–8. https://doi.org/10.1038/ijo.2015.84.
Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999;67(1):302–7.
Cattaneo A, Cattane N, Galluzzi S, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–8. https://doi.org/10.1016/j.neurobiolaging.2016.08.019.
Chaudhary PP, Conway PL, Schlundt J. Methanogens in humans: potentially beneficial or harmful for health. Appl Microbiol Biotechnol. 2018;102(7):3095–104. https://doi.org/10.1007/s00253-018-8871-2.
Chehoud C, Albenberg LG, Judge C, et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1948–56. https://doi.org/10.1097/MIB.0000000000000454.
Chen T, Kim CY, Kaur A, et al. Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. Food Funct. 2017;8(3):1166–73. https://doi.org/10.1039/c6fo01532h.
Cresci GA, Bawden E. Gut microbiome: what we do and don’t know. Nutr Clin Pract. 2015;30(6):734–46. https://doi.org/10.1177/0884533615609899.
Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin. 2006;24(3):441–60. https://doi.org/10.1016/j.ncl.2006.03.003.
Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology. 1998;115(6):1405–13. https://doi.org/10.1016/s0016-5085(98)70019-8.
De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691–6. https://doi.org/10.1073/pnas.1005963107.
de Oliveira EP, Burini RC, Jeukendrup A. Gastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendations. Sports Med. 2014;44(Suppl 1):S79–85. https://doi.org/10.1007/s40279-014-0153-2.
De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:63. https://doi.org/10.1186/1471-2180-10-63.
Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–17. https://doi.org/10.1128/JB.00542-10.
Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015;21(4):230–7. https://doi.org/10.1016/j.jiac.2015.01.011.
DiGiulio DB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med. 2012;17(1):2–11. https://doi.org/10.1016/j.siny.2011.10.001.
Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–5. https://doi.org/10.1073/pnas.1002601107.
Donia MS, Fischbach MA. Human microbiota. Small molecules from the human microbiota. Science. 2015;349(6246):1254766. https://doi.org/10.1126/science.1254766.
Dumas ME. The microbial-mammalian metabolic axis: beyond simple metabolism. Cell Metab. 2011;13(5):489–90. https://doi.org/10.1016/j.cmet.2011.04.005.
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8. https://doi.org/10.1126/science.1110591.
Edmonds-Wilson SL, Nurinova NI, Zapka CA, Fierer N, Wilson M. Review of human hand microbiome research. J Dermatol Sci. 2015;80(1):3–12. https://doi.org/10.1016/j.jdermsci.2015.07.006.
El Aidy S, van Baarlen P, Derrien M, et al. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol. 2012;5(5):567–79. https://doi.org/10.1038/mi.2012.32.
Enaud R, Vandenborght LE, Coron N, et al. The mycobiome: a neglected component in the microbiota-gut-brain axis. Microorganisms. 2018;6(1):22. https://doi.org/10.3390/microorganisms6010022.
Finegold SM, Downes J, Summanen PH. Microbiology of regressive autism. Anaerobe. 2012;18(2):260–2. https://doi.org/10.1016/j.anaerobe.2011.12.018.
Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6(2):121–31. https://doi.org/10.1038/nrmicro1817.
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–5. https://doi.org/10.1073/pnas.0706625104.
Gaci N, Borrel G, Tottey W, O’Toole PW, Brugère JF. Archaea and the human gut: new beginning of an old story. World J Gastroenterol. 2014;20(43):16062–78. https://doi.org/10.3748/wjg.v20.i43.16062.
Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 2012;12(7):503–16. https://doi.org/10.1038/nri3228.
Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100–5. https://doi.org/10.1093/jn/134.11.3100.
Genth H, Huelsenbeck J, Hartmann B, Hofmann F, Just I, Gerhard R. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett. 2006;580(14):3565–9. https://doi.org/10.1016/j.febslet.2006.04.100.
Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713. https://doi.org/10.1371/journal.ppat.1000713.
Ghavami SB, Rostami E, Sephay AA, et al. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microb Pathog. 2018;117:285–9. https://doi.org/10.1016/j.micpath.2018.01.029.
Gleeson M, Williams C. Intense exercise training and immune function. Nestle Nutr Inst Workshop Ser. 2013;76:39–50. https://doi.org/10.1159/000350254.
Gominak SC. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a “pro-inflammatory” state associated with atherosclerosis and autoimmunity. Med Hypotheses. 2016;94:103–7. https://doi.org/10.1016/j.mehy.2016.07.007.
Gonçalves P, Araújo JR, Di Santo JP. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(3):558–72. https://doi.org/10.1093/ibd/izx029.
Gopal-Srivastava R, Hylemon PB. Purification and characterization of bile salt hydrolase from Clostridium perfringens. J Lipid Res. 1988;29(8):1079–85.
Gordon JI. Honor thy gut symbionts redux. Science. 2012;336(6086):1251–3. https://doi.org/10.1126/science.1224686.
Gouba N, Drancourt M. Digestive tract mycobiota: a source of infection. Med Mal Infect. 2015;45(1–2):9–16. https://doi.org/10.1016/j.medmal.2015.01.007.
Gouba N, Hien YE, Guissou ML, et al. Digestive tract mycobiota and microbiota and the effects on the immune system. Human Microb J. 2019;12:100056. https://doi.org/10.1016/j.humic.2019.100056.
Hallen-Adams HE, Suhr MJ. Fungi in the healthy human gastrointestinal tract. Virulence. 2017;8(3):352–8. https://doi.org/10.1080/21505594.2016.1247140.
Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A. 2019;116(26):12672–7. https://doi.org/10.1073/pnas.1904099116.
Hill-Burns EM, Debelius JW, Morton JT, et al. Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32(5):739–49. https://doi.org/10.1002/mds.26942.
Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 2013;8(6):e66019. https://doi.org/10.1371/journal.pone.0066019.
Hu T, Li LF, Shen J, Zhang L, Cho CH. Chronic inflammation and colorectal cancer: the role of vascular endothelial growth factor. Curr Pharm Des. 2015;21(21):2960–7. https://doi.org/10.2174/1381612821666150514104244.
Huseyin CE, O’Toole PW, Cotter PD, Scanlan PD. Forgotten fungi-the gut mycobiome in human health and disease. FEMS Microbiol Rev. 2017;41(4):479–511. https://doi.org/10.1093/femsre/fuw047.
Ieraci A, Forni PE, Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci U S A. 2002;99(23):15200–5. https://doi.org/10.1073/pnas.222362099.
Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5(3):e9836. https://doi.org/10.1371/journal.pone.0009836.
Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63(4):559–66. https://doi.org/10.1136/gutjnl-2012-303249.
Jeffery IB, O’Toole PW, Öhman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997–1006. https://doi.org/10.1136/gutjnl-2011-301501.
Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156(Pt 11):3216–23. https://doi.org/10.1099/mic.0.040618-0.
Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94. https://doi.org/10.1016/j.bbi.2015.03.016.
Jiménez E, Fernández L, Marín ML, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51(4):270–4. https://doi.org/10.1007/s00284-005-0020-3.
Jobst D, Kraft K. Candida species in stool, symptoms and complaints in general practice—a cross-sectional study of 308 outpatients. Mycoses. 2006;49(5):415–20. https://doi.org/10.1111/j.1439-0507.2006.01244.x.
Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105(39):15064–9. https://doi.org/10.1073/pnas.0803124105.
Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut. 2011;60(5):631–7. https://doi.org/10.1136/gut.2010.223263.
Kang DW, Park JG, Ilhan ZE, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 2013;8(7):e68322. https://doi.org/10.1371/journal.pone.0068322.
Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. https://doi.org/10.1038/nature12198.
Kawashima H, Nakajima Y, Matubara Y, et al. Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in hypercholesterolemic rabbits. Jpn J Pharmacol. 1997;75(2):135–43. https://doi.org/10.1254/jjp.75.135.
Kerckhoffs APM, Ben-Amor K, Samsom M, et al. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol. 2011;60(Pt 2):236–45. https://doi.org/10.1099/jmm.0.022848-0.
Kho ZY, Lal SK. The human gut microbiome—a potential controller of wellness and disease. Front Microbiol. 2018;9:1835. https://doi.org/10.3389/fmicb.2018.01835.
Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Núñez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe. 2014;15(1):95–102. https://doi.org/10.1016/j.chom.2013.12.010.
Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8(6):423–35. https://doi.org/10.1038/nrmicro2333.
Krogius-Kurikka L, Lyra A, Malinen E, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009;9:95. https://doi.org/10.1186/1471-230X-9-95.
Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, Leys EJ. New bacterial species associated with chronic periodontitis. J Dent Res. 2003;82(5):338–44. https://doi.org/10.1177/154405910308200503.
Lagier JC, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2012;2:136. https://doi.org/10.3389/fcimb.2012.00136.
Laparra JM, Olivares M, Gallina O, Sanz Y. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One. 2012;7(2):e30744. https://doi.org/10.1371/journal.pone.0030744.
Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):e9085. https://doi.org/10.1371/journal.pone.0009085.
Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138(1):1–11. https://doi.org/10.1111/j.1365-2567.2012.03616.x.
LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24(2):160–8. https://doi.org/10.1016/j.copbio.2012.08.005.
Lederberg J, McCray AT. ‘Ome sweet ‘omics—a genealogical treasury of words genealogical treasury of words. Scientist. 2001;15(7):8.
Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol. 2014;10(6):416–24. https://doi.org/10.1038/nchembio.1535.
Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science. 2010;330(6012):1768–73. https://doi.org/10.1126/science.1195568.
Li Y, Owyang C. Musings on the wanderer: what’s new in our understanding of vago-vagal reflexes? V. Remodeling of vagus and enteric neural circuitry after vagal injury. Am J Physiol Gastrointest Liver Physiol. 2003;285(3):G461–9. https://doi.org/10.1152/ajpgi.00119.2003.
Li Q, Wang C, Tang C, He Q, Li N, Li J. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease. J Clin Gastroenterol. 2014;48(6):513–23. https://doi.org/10.1097/MCG.0000000000000035.
Li D, Wang P, Wang P, Hu X, Chen F. The gut microbiota: a treasure for human health. Biotechnol Adv. 2016;34(7):1210–24. https://doi.org/10.1016/j.biotechadv.2016.08.003.
Liguori G, Lamas B, Richard ML, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients. J Crohns Colitis. 2016;10(3):296–305. https://doi.org/10.1093/ecco-jcc/jjv209.
Lindfors K, Blomqvist T, Juuti-Uusitalo K, et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 2008;152(3):552–8. https://doi.org/10.1111/j.1365-2249.2008.03635.x.
Liu TX, Niu HT, Zhang SY. Intestinal microbiota metabolism and atherosclerosis. Chin Med J. 2015;128(20):2805–11. https://doi.org/10.4103/0366-6999.167362.
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. https://doi.org/10.1186/s13073-016-0307-y.
Lo Russo L, Campisi G, Di Fede O, Di Liberto C, Panzarella V, Lo Muzio L. Oral manifestations of eating disorders: a critical review. Oral Dis. 2008;14(6):479–84. https://doi.org/10.1111/j.1601-0825.2007.01422.x.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders [published correction appears in Gastroenterology. 2006 Aug;131(2):688]. Gastroenterology. 2006;130(5):1480–91. https://doi.org/10.1053/j.gastro.2005.11.061.
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30. https://doi.org/10.1038/nature11550.
Luan C, Xie L, Yang X, et al. Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep. 2015;5:7980. https://doi.org/10.1038/srep07980.
Lucassen PJ, Pruessner J, Sousa N, et al. Neuropathology of stress. Acta Neuropathol. 2014;127(1):109–35. https://doi.org/10.1007/s00401-013-1223-5.
Lyte M, Vulchanova L, Brown DR. Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 2011;343(1):23–32. https://doi.org/10.1007/s00441-010-1050-0.
Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–83. https://doi.org/10.1136/gutjnl-2013-304833.
Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ. 1988;297(6656):1105–6. https://doi.org/10.1136/bmj.297.6656.1105.
Malinen E, Rinttilä T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100(2):373–82. https://doi.org/10.1111/j.1572-0241.2005.40312.x.
Manrique P, Bolduc B, Walk ST, van der Oost J, de Vos WM, Young MJ. Healthy human gut phageome. Proc Natl Acad Sci U S A. 2016;113(37):10400–5. https://doi.org/10.1073/pnas.1601060113.
Mar Rodríguez M, Pérez D, Javier Chaves F, et al. Obesity changes the human gut mycobiome [published correction appears in Sci Rep. 2016;6:21679]. Sci Rep. 2015;5:14600. https://doi.org/10.1038/srep14600.
Marasco G, Di Biase AR, Schiumerini R, et al. Gut microbiota and celiac disease. Dig Dis Sci. 2016;61(6):1461–72. https://doi.org/10.1007/s10620-015-4020-2.
Martín R, Jiménez E, Heilig H, et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol. 2009;75(4):965–9.
Martinucci I, Blandizzi C, de Bortoli N, et al. Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders. Pharmacogenomics. 2015;16(5):523–39. https://doi.org/10.2217/pgs.15.12.
Maruvada P, Leone V, Kaplan LM, Chang EB. The human microbiome and obesity: moving beyond associations. Cell Host Microbe. 2017;22(5):589–99. https://doi.org/10.1016/j.chom.2017.10.005.
Matarazzo F, Ribeiro AC, Feres M, Faveri M, Mayer MP. Diversity and quantitative analysis of Archaea in aggressive periodontitis and periodontally healthy subjects. J Clin Periodontol. 2011;38(7):621–7. https://doi.org/10.1111/j.1600-051X.2011.01734.x.
Matijašić M, Meštrović T, Paljetak HČ, Perić M, Barešić A, Verbanac D. Gut microbiota beyond bacteria-mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020;21(8):2668. https://doi.org/10.3390/ijms21082668.
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014;34(46):15490–6. https://doi.org/10.1523/JNEUROSCI.3299-14.2014.
Monteiro-da-Silva F, Sampaio-Maia B, Pereira Mde L, Araujo R. Characterization of the oral fungal microbiota in smokers and non-smokers. Eur J Oral Sci. 2013;121(2):132–5. https://doi.org/10.1111/eos.12030.
Mukhopadhya I, Hansen R, Meharg C, et al. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 2015;17(4):304–10. https://doi.org/10.1016/j.micinf.2014.12.001.
Nadal I, Donant E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease (published correction appears in J Med Microbiol. 2008 Mar;57(Pt 3):401. Donant, Esther [corrected to Donat, Ester]). J Med Microbiol. 2007;56(Pt 12):1669–74. https://doi.org/10.1099/jmm.0.47410-0.
NIH HMP Working Group, Peterson J, Garges S, et al. The NIH Human microbiome project. Genome Res. 2009;19(12):2317–2323. https://doi.org/10.1101/gr.096651.109.
Nunn KL, Forney LJ. Unraveling the dynamics of the human vaginal microbiome. Yale J Biol Med. 2016;89(3):331–7.
Ochoa-Cortes F, Turco F, Linan-Rico A, et al. Enteric glial cells: a new frontier in neurogastroenterology and clinical target for inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(2):433–49. https://doi.org/10.1097/MIB.0000000000000667.
Oh J, Byrd AL, Park M, NISC Comparative Sequencing Program, Kong HH, Segre JA. Temporal stability of the human skin microbiome. Cell 2016;165(4):854–866. https://doi.org/10.1016/j.cell.2016.04.008.
Okunishi K, Dohi M, Nakagome K, et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol. 2005;175(7):4745–53. https://doi.org/10.4049/jimmunol.175.7.4745.
Ott SJ, Kühbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol. 2008;43(7):831–41. https://doi.org/10.1080/00365520801935434.
Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol. 2012;2:104. https://doi.org/10.3389/fcimb.2012.00104.
Park HK, Ha MH, Park SG, Kim MN, Kim BJ, Kim W. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS One. 2012;7(2):e32847. https://doi.org/10.1371/journal.pone.0032847.
Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54(Pt 10):987–91. https://doi.org/10.1099/jmm.0.46101-0.
Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A. 2004;101(28):10398–403. https://doi.org/10.1073/pnas.0403342101.
Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–21. https://doi.org/10.1542/peds.2005-2824.
Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;61(1):37–41. https://doi.org/10.1203/01.pdr.0000250014.92242.f3.
Pérez-Brocal V, García-López R, Nos P, Beltrán B, Moret I, Moya A. Metagenomic analysis of Crohn’s disease patients identifies changes in the virome and microbiome related to disease status and therapy, and detects potential interactions and biomarkers. Inflamm Bowel Dis. 2015;21(11):2515–32. https://doi.org/10.1097/MIB.0000000000000549.
Petersen AM, Stensvold CR, Mirsepasi H, et al. Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection. Scand J Gastroenterol. 2013;48(5):638–9. https://doi.org/10.3109/00365521.2013.780094.
Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008;3(6):417–27. https://doi.org/10.1016/j.chom.2008.05.001.
Pirbaglou M, Katz J, de Souza RJ, Stearns JC, Motamed M, Ritvo P. Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials. Nutr Res. 2016;36(9):889–98. https://doi.org/10.1016/j.nutres.2016.06.009.
Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420–8. https://doi.org/10.1038/ajg.2010.281.
Poole K. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol. 2002;3(2):77–98. https://doi.org/10.2174/1389201023378454.
Pruitt RN, Chumbler NM, Rutherford SA, et al. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J Biol Chem. 2012;287(11):8013–20. https://doi.org/10.1074/jbc.M111.298414.
Qamar A, Aboudola S, Warny M, et al. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun. 2001;69(4):2762–5. https://doi.org/10.1128/IAI.69.4.2762-2765.2001.
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. https://doi.org/10.1038/nature08821.
Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. https://doi.org/10.1038/nature11450.
Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis. 1998;27(Suppl 1):S117–24. https://doi.org/10.1086/514912.
Rajilić-Stojanović M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol. 2007;9(9):2125–36. https://doi.org/10.1111/j.1462-2920.2007.01369.x.
Rajilić-Stojanović M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–801. https://doi.org/10.1053/j.gastro.2011.07.043.
Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog. 2011;3(1):6. https://doi.org/10.1186/1757-4749-3-6.
Rizzo A, Losacco A, Carratelli CR. Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human β-defensins 2 and 3. Immunol Lett. 2013;156(1–2):102–9. https://doi.org/10.1016/j.imlet.2013.08.013.
Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes. 2010;1(4):279–84. https://doi.org/10.4161/gmic.1.4.12614.
Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11(1):76–83. https://doi.org/10.1038/ni.1825.
Sam QH, Chang MW, Chai LY. The fungal mycobiome and its interaction with gut bacteria in the host. Int J Mol Sci. 2017;18(2):330. https://doi.org/10.3390/ijms18020330.
Samonis G, Gikas A, Anaissie EJ, et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother. 1993;37(1):51–3. https://doi.org/10.1128/aac.37.1.51.
Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A. 2006;103(26):10011–6. https://doi.org/10.1073/pnas.0602187103.
Satokari R, Grönroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol. 2009;48(1):8–12. https://doi.org/10.1111/j.1472-765X.2008.02475.x.
Scott DA, Coulter WA, Lamey PJ. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med. 1997;26(10):441–7. https://doi.org/10.1111/j.1600-0714.1997.tb00012.x.
Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest. 2006;116(5):1150–8. https://doi.org/10.1172/JCI28521.
Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859–904. https://doi.org/10.1152/physrev.00045.2009.
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. https://doi.org/10.1371/journal.pbio.1002533.
Shafquat A, Joice R, Simmons SL, Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol. 2014;22(5):261–6. https://doi.org/10.1016/j.tim.2014.01.011.
Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–6. https://doi.org/10.1073/pnas.0804812105.
Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039–48. https://doi.org/10.1136/gutjnl-2015-310746.
Solbiati J, Frias-Lopez J. Metatranscriptome of the oral microbiome in health and disease. J Dent Res. 2018;97(5):492–500. https://doi.org/10.1177/0022034518761644.
Sommer F, Bäckhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–38. https://doi.org/10.1038/nrmicro2974.
Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004;70(11):6459–65. https://doi.org/10.1128/AEM.70.11.6459-6465.2004.
Song HJ, Shim KN, Jung SA, et al. Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile. Korean J Intern Med. 2008;23(1):9–15. https://doi.org/10.3904/kjim.2008.23.1.9.
Spencer NJ, Hibberd TJ, Travis L, et al. Identification of a rhythmic firing pattern in the enteric nervous system that generates rhythmic electrical activity in smooth muscle. J Neurosci. 2018;38(24):5507–22. https://doi.org/10.1523/JNEUROSCI.3489-17.2018.
Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol. 1982;15(2):189–203. https://doi.org/10.1099/00222615-15-2-189.
Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective. Mycologia. 2015;107(6):1057–73. https://doi.org/10.3852/15-147.
Swidergall M, Ernst JF. Interplay between Candida albicans and the antimicrobial peptide armory. Eukaryot Cell. 2014;13(8):950–7. https://doi.org/10.1128/EC.00093-14.
Takata K, Tomita T, Okuno T, et al. Dietary yeasts reduce inflammation in central nerve system via microflora. Ann Clin Transl Neurol. 2015;2(1):56–66. https://doi.org/10.1002/acn3.153.
Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4. https://doi.org/10.1136/gut.53.1.1.
Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–55. https://doi.org/10.1161/CIRCRESAHA.116.305360.
Tetel MJ, de Vries GJ, Melcangi RC, Panzica G, O’Mahony SM. Steroids, stress and the gut microbiome-brain axis. J Neuroendocrinol. 2018;30(2):12548. https://doi.org/10.1111/jne.12548.
Theriot CM, Koenigsknecht MJ, Carlson PE Jr, et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014;5:3114. https://doi.org/10.1038/ncomms4114.
Thomas S, Metzke D, Schmitz J, Dörffel Y, Baumgart DC. Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn’s disease and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2011;301(6):G1083–92. https://doi.org/10.1152/ajpgi.00217.2011.
Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12(8):782–6. https://doi.org/10.1111/j.1469-0691.2006.01494.x.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–31. https://doi.org/10.1038/nature05414.
Ungaro F, Massimino L, D’Alessio S, Danese S. The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches. United European Gastroenterol J. 2019;7(8):999–1007. https://doi.org/10.1177/2050640619876787.
Unger MM, Spiegel J, Dillmann KU, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. https://doi.org/10.1016/j.parkreldis.2016.08.019.
Vemuri R, Shankar EM, Chieppa M, Eri R, Kavanagh K. Beyond just bacteria: functional biomes in the gut ecosystem including virome, mycobiome, archaeome and helminths. Microorganisms. 2020;8(4):E483. https://doi.org/10.3390/microorganisms8040483.
Voropaeva EA. Antibiotikorezistentnost’ i produktsiia gistamina u bakteriĭ, izolirovannykh iz rotogloki deteĭ, stradaiushchikh bronkhial’noĭ astmoĭ [Resistance to antibiotics and histamine production at the bacteria, isolated from the stomatopharynx of the children with bronchial asthma]. Antibiot Khimioter. 2002;47(3):8–13.
Wade WG. The oral microbiome in health and disease. Pharmacol Res. 2013;69(1):137–43. https://doi.org/10.1016/j.phrs.2012.11.006.
Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014;817:221–39. https://doi.org/10.1007/978-1-4939-0897-4_10.
Wang LW, Tancredi DJ, Thomas DW. The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J Dev Behav Pediatr. 2011;32(5):351–60. https://doi.org/10.1097/DBP.0b013e31821bd06a.
Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320–9. https://doi.org/10.1038/ismej.2011.109.
Weinstock GM. Genomic approaches to studying the human microbiota. Nature. 2012;489(7415):250–6. https://doi.org/10.1038/nature11553.
White JF. Syntrophic imbalance and the etiology of bacterial endoparasitism diseases. Med Hypotheses. 2017;107:14–5. https://doi.org/10.1016/j.mehy.2017.07.015.
Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 2012;3(1):e00261–11. https://doi.org/10.1128/mBio.00261-11.
Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844–1854.e1. https://doi.org/10.1053/j.gastro.2010.08.049.
Witherden EA, Shoaie S, Hall RA, Moyes DL. The human mucosal mycobiome and fungal community interactions. J Fungi. 2017;3(4):56. https://doi.org/10.3390/jof3040056.
Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev. 2005;57(10):1451–70. https://doi.org/10.1016/j.addr.2005.04.002.
Wu N, Yang X, Zhang R, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol. 2013;66(2):462–70. https://doi.org/10.1007/s00248-013-0245-9.
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7. https://doi.org/10.1038/nature11053.
Yu YB, Li YQ. Enteric glial cells and their role in the intestinal epithelial barrier. World J Gastroenterol. 2014;20(32):11273–80. https://doi.org/10.3748/wjg.v20.i32.11273.
Zhang E, Tanaka T, Tajima M, Tsuboi R, Nishikawa A, Sugita T. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol. 2011;55(9):625–32. https://doi.org/10.1111/j.1348-0421.2011.00364.x.
Zhang X, Shen D, Fang Z, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8(8):e71108. https://doi.org/10.1371/journal.pone.0071108.
Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 2004;150(Pt 8):2565–73. https://doi.org/10.1099/mic.0.26905-0.
Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4653–8. https://doi.org/10.1073/pnas.1000083107.
Zuo T, Lu XJ, Zhang Y, et al. Gut mucosal virome alterations in ulcerative colitis. Gut. 2019;68(7):1169–79. https://doi.org/10.1136/gutjnl-2018-318131.
Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A, Haslberger AG. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol. 2009;44(6–7):440–6. https://doi.org/10.1016/j.exger.2009.04.002.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Andreou, NP., Gazouli, M. (2021). The Human Microbiome. In: Gazouli, M., Theodoropoulos, G. (eds) Gut Microbiome-Related Diseases and Therapies. The Microbiomes of Humans, Animals, Plants, and the Environment, vol 1. Springer, Cham. https://doi.org/10.1007/978-3-030-59642-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-59642-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59641-5
Online ISBN: 978-3-030-59642-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)